NCT02568319View on ClinicalTrials.gov

Safety and Efficacy Study of LIPO-202 for the Reduction of Central Abdominal Bulging in Obese Subjects

PHASE2CompletedINTERVENTIONAL
Enrollment

120

Participants

Timeline

Start Date

September 30, 2015

Primary Completion Date

December 31, 2015

Conditions
Central Abdominal Bulging
Interventions
DRUG

LIPO-202

DRUG

Placebo

Trial Locations (6)

22911

Charlottesville Medical Research Center, Charlottesville

33146

Skin Research Institute, Coral Gables

33180

The Center for Clinical & Cosmetic Research, Aventura

37215

Tennessee Clinical Research Center, Nashville

90266

Ablon Skin Institute and Research Center, Manhattan Beach

92024

Diagnamics, Inc., Encinitas

Sponsors

Lead Sponsor

Neothetics, Inc
All Listed Sponsors
lead

Neothetics, Inc

INDUSTRY